HistoSonics, Inc.

We are honored to share that HistoSonics, Inc. has been named one of TIME’s 10 Most Influential Companies in Health & Life Sciences for 2026 as part of the inaugural TIME100 Companies Industry Leaders list. This recognition highlights organizations making an extraordinary impact across their industries—selected through global nominations and evaluated by TIME editors on innovation, ambition, impact, and success. It is an honor to be recognized alongside other companies shaping the future of healthcare. This milestone reflects the dedication of our team and our continued commitment to advancing non-invasive histotripsy, delivering new hope to patients who need it most. See the full list: https://lnkd.in/e7adG8m4 #TIME100 #TIME100CompaniesIndustryLeader #HealthcareInnovation #LifeSciences #MedTech #Innovation #Histotripsy #HistoSonics

If you’re attending the Society of Interventional Radiology (SIR) meeting in Toronto, Canada April 11-15th, join us for a Breakfast Symposium to hear how histotripsy is transitioning from innovation to implementation. 🗓️HISTOTRIPSY IN PRACTICE: REAL-WORLD EXPERIENCE, EVIDENCE, AND FUTURE FRONTIERS ➡️WHEN: Tuesday, April 14th ➡️TIME: 7:45am-8:30am with breakfast available starting at 7:30am ➡️LOCATION: Room 718B, Metro Toronto Convention Center SPEAKERS: Kevin Burns, MD, Interventional Radiologist at Mission Hospital, Mikhail Silk, MD, Interventional Radiologist at NYU Langone Health, Jordan Tasse, MD, Interventional Radiologist at Rush University. Moderated by Paul Laeseke, MD, Interventional Radiologist at the University of Wisconsin. We hope to see you there! The HistoSonics team will be available for discussions about the Edison #Histotripsy System and our supporting imaging technology Samsung® R20 Ultrasound System at Booth #1401 on the exhibition floor. Disclaimer: Use of the Edison System outside of liver applications is limited to clinical investigations.

HistoSonics, Inc. Chairman and CEO, Mike Blue, looks forward to the Keynote Interview at DeviceTalks Minnesota on May 4th and discussing our 2025 management-led majority stake acquisition for $2.25B, the new syndicate of globally recognized private and public investors and what it means, and our plans to deliver on the future of non-invasive surgery. We look forward to seeing you there. #DeviceTalksMinnesota

HistoSonics, Inc. announces today the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison #Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. “BPH affects millions of men worldwide and most of the existing treatment options require invasive procedures or lengthy recovery times,” said Mike Blue, Chairman and CEO, HistoSonics. “We believe histotripsy’s ability to mechanically destroy targeted tissue, completely non-invasively, has the potential to transform how BPH is treated. In addition, this milestone represents significant progress in our pursuit to expand the unique benefits of histotripsy over a significant number of serious clinical conditions throughout the body.” 🔗 Read our release: https://lnkd.in/g_eUthhF #HistoSonics #Histotripsy #MedTech #EdisonSystem #PatientsFirst

HistoSonics, Inc. is ready to connect with you at the Society of Interventional Radiology (SIR) Annual Scientific Meeting in Toronto, Canada April 11-15th. 🗓️DINNER EVENT: Join HistoSonics, Inc. Leadership and #Histotripsy Experts for an exclusive discussion bringing together histotripsy users and emerging adopters. HISTOTRIPSY: CLINICAL EVOLUTION AND MERGING APPLICATIONS ➡️WHEN: Monday, April 13th from 6:30-9:00pm ➡️WHERE: Blue Ristorante & Lounge ➡️SPEAKERS: Mike Blue, President and CEO of HistoSonics, Joshua Stopek, PhD, CTO of HistoSonics, Kevin Burns, MD, Interventional Radiologist at Mission Hospital, Mikhail Silk, MD, Interventional Radiologist at NYU Langone Health. Moderated by Paul Laeseke, MD, Interventional Radiologist at the University of Wisconsin. ➡️RSVP: If you are interested in attending this dinner, RSVP by filling out this form as space is limited! https://lnkd.in/gVqkhntc The HistoSonics team will be available for discussions about the Edison #Histotripsy System at booth #1401 on the exhibition floor. Disclaimer: Use of the Edison System outside of liver applications is limited to clinical investigations.

DeviceTalks Minnesota returns May 4 in Minneapolis with a keynote lineup worth planning around. This year's featured speakers include: - Mike Blue, Chairman & CEO, HistoSonics, Inc. - Lisa Earnhardt, EVP & Group President, Medical Devices, Abbott - Heather Knight, Chief Commercial Officer, Solventum Three leaders. One day. One focused conversation about where medtech is headed. #DeviceTalksMinnesota #MedTech #MedicalDevices #Leadership #Minneapolis

If you’re attending AHPBA in Miami Beach, FL March 19-22nd, join us for a Lunch Symposium to hear how histotripsy is transitioning from innovation to implementation. 🗓️HISTOTRIPSY IN PRACTICE: REAL-WORLD EXPERIENCE, EVIDENCE, AND FUTURE FRONTIERS ➡️WHEN: Friday, March 20th ➡️TIME: 12:00pm-12:45pm with lunch available starting at 11:45am ➡️LOCATION: Poinciana 3&4, Loews Miami Beach Hotel SPEAKERS: Young K. Hong, MD, MPH, FACS,FSSO, Surgical Oncologist, MD Anderson Cancer Center at Cooper and Sekhar Padmanabhan, MD, FACS, FSSO, General Surgery, Assistant Professor, Vanderbilt University. No RSVP needed; we hope to see you there! The HistoSonics team will be available for discussions about the Edison #Histotripsy System at booth #32/33 on the exhibition floor. Disclaimer: Use of the Edison System outside of liver applications is limited to clinical investigations.

At HistoSonics, our mission is to deliver #NewHope to patients who need it most. Patients like Jon, a devoted husband, father, and grandfather. After a sudden diagnosis of stage 4 pancreatic cancer with liver metastases and starting chemotherapy, the treatment eventually stopped working and began taking a serious toll on his quality of life. Jon was determined to find another option. When his family members learned about histotripsy, Jon found #NewHope. Jon's story is one of resilience, love, and hope. It serves as a powerful reminder of the impact histotripsy can have for patients around the world. Watch Jon's heartwarming story: https://lnkd.in/gwgcwTFC

HistoSonics, Inc. is ready to connect with you at the AHPBA Annual Meeting in Miami Beach, FL on March 19-22nd. 🗓️DINNER EVENT: Join us for an exclusive, peer-driven forum designed for current and emerging histotripsy users. HISTOTRIPSY IN PRACTICE: A CLINICAL FORUM ➡️WHEN: Thursday, March 19th from 7:00-10:00pm ➡️WHERE: Gale South Beach Hotel ➡️SPEAKER: Young K. Hong, MD, MPH, FACS,FSSO, Surgical Oncologist, MD Anderson Cancer Center at Cooper ➡️RSVP: If you are interested in attending this dinner, RSVP by filling out this form as space is limited! https://lnkd.in/g-6JQmjT The HistoSonics team will be available for discussions about the Edison #Histotripsy System at booth #32/33 on the exhibition floor. Disclaimer: Use of the Edison System outside of liver applications is limited to clinical investigations.